Proof of the Concept to Use a Malignant B Cell Line Drug Screen Strategy for Identification and Weight of Melphalan Resistance Genes in Multiple Myeloma-Reference-Cited by-同舟云学术

Proof of the Concept to Use a Malignant B Cell Line Drug Screen Strategy for Identification and Weight of Melphalan Resistance Genes in Multiple Myeloma

Published:2013-12-20 Issue:12 Volume:8 Page:e83252
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bøgsted Martin,Bilgrau Anders E.,Wardell Christopher P.,Bertsch Uta,Schmitz Alexander,Bødker Julie S.,Kjeldsen Malene K.,Goldschmidt Hartmut,Morgan Gareth J.,Dybkaer Karen,Johnsen Hans E.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference57 articles.

1. Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006;HH Storm;Acta Oncol,2010

2. Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN);A Palumbo;Blood,2011

3. International Myeloma Working Group. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review;R Fonseca;Leukemia,2009

4. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma;PL Bergsagel;Blood,2005

5. International staging system for multiple myeloma. J Clin Oncol 23: 3412–3420. Epub 2005 Apr 4;PR Greipp;Erratum (2005) J Clin Oncol,2005

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct Pathway Activities are Associated with Prognosis and Response to Bortezomib- containing Treatment in MCL1-M Based Molecular Subtypes of Multiple Myeloma;2024-03-05

2. Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, Denmark;Cancers;2020-01-29

3. A bendamustine resistance gene signature in diffuse large B-cell lymphoma and multiple myeloma;Cancer Drug Resistance;2020

4. Therapeutic Targets and Signaling Pathways for Diagnosis of Myeloma;Update on Multiple Myeloma;2019-02-20

5. A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis;Blood Advances;2018-09-25